Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7455
-0.0247 (-3.21%)
Sep 2, 2026, 3:36 PM EDT - Market open
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $11.4 million as of September 2, 2026. Its market cap has decreased by -58.09% in one year.
Market Cap
11.40M
Enterprise Value
5.54M
1-Year Change
-58.09%
Ranking
Category
Stock Price
$0.75
ChartMarket Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $11.40M, a decrease of -88.37%. That is a compound annual growth rate of -15.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 11.40M | -58.70% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 12.78M |
| Moleculin Biotech | 12.66M |
| Aspire Biopharma Holdings | 12.50M |
| BioLineRx | 12.25M |
| Theriva Biologics | 11.43M |
| PDS Biotechnology | 11.42M |
| MetaVia | 11.33M |
| Kiora Pharmaceuticals | 11.11M |